Skip to contentV
Vsee Health, Inc.
V
VSEEWVsee Health, Inc. Q3 2025 · 10-Q
Revenue$3.98M$3.98M+18.7% vs Q3 2024 Net Income-$289.75K-$289.75KN/M vs Q3 2024 EPS Diluted-$0.02-$0.02N/M vs Q3 2024 Gross Profit$2,073,296−25.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vsee Health, Inc. · CIK 1864531 · Engraved from SEC EDGAR
Operating Cash Flowderived-$754,538N/M Free Cash Flowderived-$777,314N/M Margins · derivedGross margin52.1%−30.9 pt vs Q3 2024
Operating margin-51.7%+1686.2 pt vs Q3 2024
Net margin-7.3%+1600.2 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 14, 2025 · 45 d after period end